Physician
Shenoy, Divya
Shenoy, Divya was paid $6.16M by Medicaid between Sep 2018 and Sep 2022, across 67 billing codes. Its largest line is J7307, Etonogestrel (contraceptive) implant system, including implant and supplies — 17% of everything it billed.
33Billing provider infoSHENOY, DIVYA
WASHINGTON, DC 20002
WASHINGTON, DC 20002
33aNPI1215322797assigned 04/01/2015
33bProvider typeFamily Medicine Physician
28Total paid$6.16M
24GClaims142,011
24DCodes billed67
24AFirst – last monthSep 2018 – Sep 2022
Compared with peers
Next to other Family Medicine Physician providers in District of Columbia
Rank by total paid#1 of 42
Median peer was paid$3K
This provider vs. median1,830×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,320 | $133K | |
| 2019 | 44,361 | $1.74M | |
| 2020 | 30,168 | $1.36M | |
| 2021 | 37,546 | $1.66M | |
| 2022 | 25,616 | $1.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 17% | 1,287 | 1,272 | $1.06M |
| S4993 | Contraceptive pills for birth control | 11% | 3,666 | 3,581 | $689K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 10% | 14,023 | 13,729 | $624K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9.8% | 14,027 | 13,731 | $607K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.4% | 9,569 | 8,529 | $518K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.7% | 12,987 | 10,989 | $413K |
| J7304 | Contraceptive supply, hormone containing patch, each | 5.5% | 383 | 364 | $336K |
| 90651 | 4.3% | 1,139 | 1,114 | $265K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 4.1% | 3,755 | 3,547 | $254K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 3.0% | 318 | 314 | $184K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.2% | 1,456 | 1,348 | $138K |
| J3490 | Unclassified drugs | 2.1% | 5,295 | 5,013 | $131K |
55 more codes
| A4267 | Contraceptive supply, condom, male, each | 2.1% | 10,996 | $129K |
| 11981 | 1.7% | 530 | $105K | |
| 87806 | 1.4% | 4,091 | $87K | |
| 11976 | 1.3% | 1,244 | $80K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 2,668 | $69K |
| 90674 | <1% | 1,750 | $53K | |
| 81025 | <1% | 17,976 | $53K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 475 | $48K |
| Q3014 | Telehealth originating site facility fee | <1% | 2,697 | $47K |
| 96156 | <1% | 675 | $45K | |
| 58300 | <1% | 398 | $43K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 451 | $32K |
| 99385 | <1% | 180 | $16K | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 226 | $16K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 323 | $15K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 14 | $12K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 62 | $12K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 2,865 | $11K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 695 | $11K |
| 83986 | <1% | 2,867 | $9K | |
| 99000 | <1% | 3,134 | $8K | |
| 58301 | <1% | 257 | $8K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 1,437 | $7K |
| 90715 | <1% | 139 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,571 | $5K |
| 81002 | <1% | 1,545 | $3K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 240 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 507 | $3K |
| 96150 | <1% | 251 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 915 | $2K |
| 96127 | <1% | 494 | $2K | |
| 86580 | <1% | 138 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 14 | $1K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 12 | $1K |
| 90746 | <1% | 12 | $886.40 | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 230 | $794.20 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 106 | $548.28 |
| 85018 | <1% | 637 | $532.59 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 64 | $170.19 |
| 87430 | <1% | 12 | $130.95 | |
| 96151 | <1% | 31 | $48.66 | |
| S5001 | Prescription drug, brand name | <1% | 392 | $1.18 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 397 | $1.05 |
| 3078F | 0% | 797 | $0.00 | |
| S5000 | Prescription drug, generic | 0% | 2,834 | $0.00 |
| 1160F | 0% | 1,181 | $0.00 | |
| 1159F | 0% | 1,181 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 129 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 37 | $0.00 |
| 99442 | 0% | 60 | $0.00 | |
| 2000F | 0% | 842 | $0.00 | |
| 3074F | 0% | 833 | $0.00 | |
| 1036F | 0% | 929 | $0.00 | |
| 3008F | 0% | 552 | $0.00 | |
| 99441 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.